- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x LRZ: methyl 6-[3-[[~{N}-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl]carbamimidoyl]amino]propylcarbamoylamino]-4-oxidanyl-naphthalene-2-carboxylate(Non-covalent)
- 18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 3 residues within 4Å:- Chain A: Q.45, L.49, Q.76
Ligand excluded by PLIPEDO.3: 6 residues within 4Å:- Chain A: D.37, L.284, T.285, H.286, Y.288, Y.348
Ligand excluded by PLIPEDO.4: 6 residues within 4Å:- Chain A: Y.21, F.24, Y.25, E.138, K.342
- Ligands: LRZ.1
Ligand excluded by PLIPEDO.5: 6 residues within 4Å:- Chain A: D.213, R.347, T.349, T.351, P.353, S.354
Ligand excluded by PLIPEDO.6: 4 residues within 4Å:- Chain A: A.314, N.315, K.316, R.317
Ligand excluded by PLIPEDO.7: 3 residues within 4Å:- Chain A: D.264, W.275, S.277
Ligand excluded by PLIPEDO.9: 6 residues within 4Å:- Chain B: Q.20, Y.21, F.24, Y.25, E.138
- Ligands: LRZ.8
Ligand excluded by PLIPEDO.10: 6 residues within 4Å:- Chain B: D.37, L.284, T.285, H.286, Y.288, Y.348
Ligand excluded by PLIPEDO.11: 6 residues within 4Å:- Chain B: K.148, L.151, K.152, P.153, G.155, L.232
Ligand excluded by PLIPEDO.13: 3 residues within 4Å:- Chain C: Q.45, L.49, Q.76
Ligand excluded by PLIPEDO.14: 6 residues within 4Å:- Chain C: D.37, L.284, T.285, H.286, Y.288, Y.348
Ligand excluded by PLIPEDO.15: 6 residues within 4Å:- Chain C: Y.21, F.24, Y.25, E.138, K.342
- Ligands: LRZ.12
Ligand excluded by PLIPEDO.16: 6 residues within 4Å:- Chain C: D.213, R.347, T.349, T.351, P.353, S.354
Ligand excluded by PLIPEDO.17: 4 residues within 4Å:- Chain C: A.314, N.315, K.316, R.317
Ligand excluded by PLIPEDO.18: 3 residues within 4Å:- Chain C: D.264, W.275, S.277
Ligand excluded by PLIPEDO.20: 6 residues within 4Å:- Chain D: Q.20, Y.21, F.24, Y.25, E.138
- Ligands: LRZ.19
Ligand excluded by PLIPEDO.21: 6 residues within 4Å:- Chain D: D.37, L.284, T.285, H.286, Y.288, Y.348
Ligand excluded by PLIPEDO.22: 6 residues within 4Å:- Chain D: K.148, L.151, K.152, P.153, G.155, L.232
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Iannelli, G. et al., Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach. J.Med.Chem. (2022)
- Release Date
- 2022-04-06
- Peptides
- Histone-arginine methyltransferase CARM1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x LRZ: methyl 6-[3-[[~{N}-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl]carbamimidoyl]amino]propylcarbamoylamino]-4-oxidanyl-naphthalene-2-carboxylate(Non-covalent)
- 18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Iannelli, G. et al., Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach. J.Med.Chem. (2022)
- Release Date
- 2022-04-06
- Peptides
- Histone-arginine methyltransferase CARM1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B